James J. Lee PhD

Dr. Lee was particularly interested in the concept of eosinophils as key mediators of immune regulation and tissue remodeling. Most recently, Lees and colleagues introduced eoCre, which also uses the eosinophil peroxidase gene promoter to direct expression of Cre recombinase, resulting in a means to generate eosinophil-specific gene deletions. Together with his development of gold-standard reagents, such as antibodies recognizing eosinophil granule proteins, eosinophil biology has grown and flourished in no small part because of the generosity of the Lee laboratories. Dr. Lee has held many important posts and responsibilities, including past President of the International Eosinophil Society, where he also served on the Board of Directors. He was a member of the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases and served as CoEditor in Chief for the multi-author text Eosinophils in health and disease.